Literature DB >> 18795832

Ethics and severe pandemic influenza: maintaining essential functions through a fair and considered response.

Nancy E Kass1, Jean Otto, Daniel O'Brien, Matthew Minson.   

Abstract

The response to severe pandemic influenza will be managed by experts in public health and infectious disease and by government officials to whom the public will turn for information and direction. Nonetheless, there remain important ethical considerations that can shape what goals are given priority, how scarce resources are distributed, how the public is included, and how we treat the most vulnerable in our response to a pandemic. This article assumes that the secondary consequences of severe pandemic influenza could be greater than deaths and illness from influenza itself. Response plans, then, must consider threats to societal as well as medical infrastructures. While some have suggested that scarce medical countermeasures be allocated primarily to first responders and then to the sickest, we suggest that an ethical public health response should set priorities based on essential functions. An ethical response also will engage the public, will coordinate interdependent sectors as a core preparedness priority, and will address how plans affect and can be understood by the least well off.

Entities:  

Mesh:

Year:  2008        PMID: 18795832     DOI: 10.1089/bsp.2008.0020

Source DB:  PubMed          Journal:  Biosecur Bioterror        ISSN: 1538-7135


  10 in total

1.  Lay people's interpretation of ethical values related to mass vaccination; the case of A(H1N1) vaccination campaign in the province of Quebec (French Canada).

Authors:  Raymond Massé; Michel Désy
Journal:  Health Expect       Date:  2012-09-28       Impact factor: 3.377

2.  Stockpiling Basic Medical Equipment for Public Health Emergencies and "The-Right-Thing-To-Do." Charting the Ethical Territory.

Authors:  Andrea Martani
Journal:  Int J Public Health       Date:  2022-05-30       Impact factor: 5.100

3.  Willingness of the local health department workforce to respond to infectious disease events: empirical, ethical, and legal considerations.

Authors:  Holly A Taylor; Lainie Rutkow; Daniel J Barnett
Journal:  Biosecur Bioterror       Date:  2014-06-25

4.  The prevalence of asymptomatic carriers of COVID-19 as determined by routine preoperative testing.

Authors:  Joshua A Bloom; Zachary Erlichman; Tina Tian; Shira Doron; Lilian Chen; Kristen Mansur; Michael E Tarnoff
Journal:  J Infect Prev       Date:  2020-11-06

5.  Immunization against A/H1N1 pandemic flu (2009-2010) in pediatric patients at risk. What might be the most effective strategy? The experience of an health district of Northern Italy.

Authors:  Giuseppe Gregori; Fabio Faccini; Ermanno Bongiorni; Ilario Maffini; Roberto Sacchetti
Journal:  Ital J Pediatr       Date:  2012-05-17       Impact factor: 2.638

Review 6.  Prioritising access to pandemic influenza vaccine: a review of the ethics literature.

Authors:  Jane H Williams; Angus Dawson
Journal:  BMC Med Ethics       Date:  2020-05-14       Impact factor: 2.652

7.  Ethical values and principles to guide the fair allocation of resources in response to a pandemic: a rapid systematic review.

Authors:  Lydia O'Sullivan; Edelweiss Aldasoro; Áine O'Brien; Maeve Nolan; Cliona McGovern; Áine Carroll
Journal:  BMC Med Ethics       Date:  2022-07-07       Impact factor: 2.834

8.  Measuring Italian citizens' engagement in the first wave of the COVID-19 pandemic containment measures: A cross-sectional study.

Authors:  Guendalina Graffigna; Serena Barello; Mariarosaria Savarese; Lorenzo Palamenghi; Greta Castellini; Andrea Bonanomi; Edoardo Lozza
Journal:  PLoS One       Date:  2020-09-11       Impact factor: 3.240

9.  Avian flu pandemic - flight of the healthcare worker?

Authors:  Robert B Shabanowitz; Judith E Reardon
Journal:  HEC Forum       Date:  2009-12

10.  Pilot-testing an applied competency-based approach to health human resources planning.

Authors:  Gail Tomblin Murphy; Adrian MacKenzie; Rob Alder; Joanne Langley; Marjorie Hickey; Amanda Cook
Journal:  Health Policy Plan       Date:  2012-11-27       Impact factor: 3.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.